Navigator Medicines
NJ - Scotch PlainsBiotechnology
Focus: Navigator Medicines is a pre-revenue biotech company focused on bispecific antibody development for immunology and dermatology indications. The company is early-stage with minimal disclosed operational scale.
Profile data last refreshed 23h ago · AI intelligence enriched 2w ago
Open Jobs
1-2 this month
Stable — net -2 jobs in 30d
1 added, 3 removed. Backfill posture.
Should You Work at Navigator Medicines?
AI assessmentNavigator Medicines is a speculative early-stage bet suitable only for risk-tolerant scientists who value technology ownership over near-term compensation certainty.
Why Work Here
- Ground-floor opportunity at a focused biotech with a clear technological differentiation in bispecific antibodies, attractive for scientists seeking early-stage impact
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
NAV-240
Healthy VolunteersClinical Trials (1)
NCT06933043A Study on the Safety, Tolerability, Bioavailability and Mechanism of Action of Intravenous NAV-240 in Adults.
Phase 1Help build intelligence for Navigator Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.